The functional roles, cross-talk and clinical implications of m6A modification and circRNA in hepatocellular carcinoma.

导出 OA

翻译打印收藏纠错

作者： Sha,Qin ^[1] ; Yitao,Mao ^[2] ; Xue,Chen ^[3] ; Juxiong,Xiao ^[4] ; Yan,Qin ^[2] ; Luqing,Zhao ^[2]

作者单位： Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan, China; and Department of Pathology, School of Basic Medical Science, Xiangya School of Medicine, Central South University, Changsha, Hunan, China. ^[1] Department of Radiology, Xiangya Hospital, Central South University, Changsha, Hunan, China. ^[2] National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China. ^[3] Early Clinical Trial Center, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China. ^[4]

关键词 Biomarkers Hepatocellular carcinoma (HCC)N6-methyladenosine (m6A) modification Therapeutic targets circRNA

主题词腺苷(Adenosine);癌, 肝细胞(Carcinoma, Hepatocellular);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);肝肿瘤(Liver Neoplasms);预后(Prognosis)

DOI 10.7150/ijbs.62767

PMID 34421350

发布时间 2022-03-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交